Beta-blockade in heart failure: selective versus nonselective agents.

about

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.Long-term oral carvedilol in chronic heart failure.Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace?

P2860

Q35006600-9CF59706-BB4D-411A-904F-3007C05D9A74 Q44910691-D32E5689-E799-4771-A7D5-19D231310CEE Q46838656-40898B06-368E-42AD-848D-09E7807C247E

P2860

Beta-blockade in heart failure: selective versus nonselective agents.

Item

http://www.wikidata.org/entity/Q35631382

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Beta-blockade in heart failure: selective versus nonselective agents.

@ast

Beta-blockade in heart failure: selective versus nonselective agents.

@en

type

Item

label

Beta-blockade in heart failure: selective versus nonselective agents.

@ast

Beta-blockade in heart failure: selective versus nonselective agents.

@en

prefLabel

Beta-blockade in heart failure: selective versus nonselective agents.

@ast

Beta-blockade in heart failure: selective versus nonselective agents.

@en

P1476

Beta-blockade in heart failure: selective versus nonselective agents.

@en

P2093

Dei Cas L

http://www.w3.org/2001/XMLSchema#string

Nodari S

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?

Recent advances in cardiac beta(2)-adrenergic signal transduction.

beta-adrenergic receptor blockade in chronic heart failure.

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.

Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis.

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.

Renal nerve stimulation causes alpha 1-adrenoceptor-mediated sodium retention but not alpha 2-adrenoceptor antagonism of vasopressin.

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.

P2888

00129784-200101010-00001

P304

3-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2165/00129784-200101010-00001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Metra

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030014402

http://www.w3.org/2001/XMLSchema#string

P698

14728047

http://www.w3.org/2001/XMLSchema#string

Beta-blockade in heart failure: selective versus nonselective agents.

about

P2860

P2860

Beta-blockade in heart failure: selective versus nonselective agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698